Ładuje się......
Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage
Ranolazine received Food and Drug Administration (FDA) approval in 2006 for the treatment of chronic angina. Ranolazine has previously been linked to the development of statin-induced myopathy, because it also inhibits CYP3A4, which increases serum statin levels. In the absence of concomitant statin...
Zapisane w:
| Wydane w: | Cureus |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Cureus
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101463/ https://ncbi.nlm.nih.gov/pubmed/30131925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2832 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|